95 related articles for article (PubMed ID: 6747823)
1. Effects of calcium antagonists and vasodilators on arterial myosin phosphorylation and actin-myosin interactions.
Silver PJ; Dachiw J; Ambrose JM
J Pharmacol Exp Ther; 1984 Jul; 230(1):141-8. PubMed ID: 6747823
[TBL] [Abstract][Full Text] [Related]
2. Effects of the calcium antagonists perhexiline and cinnarizine on vascular and cardiac contractile protein function.
Silver PJ; Dachiw J; Ambrose JM; Pinto PB
J Pharmacol Exp Ther; 1985 Sep; 234(3):629-35. PubMed ID: 3162016
[TBL] [Abstract][Full Text] [Related]
3. Effects of felodipine, nitrendipine and W-7 on arterial myosin phosphorylation, actin-myosin interactions and contraction.
Silver PJ; Ambrose JM; Michalak RJ; Dachiw J
Eur J Pharmacol; 1984 Jul; 102(3-4):417-24. PubMed ID: 6489434
[TBL] [Abstract][Full Text] [Related]
4. Wy-46,300 and Wy-46,531: vascular smooth muscle relaxant/antihypertensive agents with combined Ca2+ antagonist/myosin phosphorylation inhibitory mechanisms.
Silver PJ; Sulkowski TS; Lappe RW; Wendt RL
J Cardiovasc Pharmacol; 1986; 8(6):1168-75. PubMed ID: 2434743
[TBL] [Abstract][Full Text] [Related]
5. Thyroid hormones directly interact with vascular smooth muscle strips.
Ishikawa T; Chijiwa T; Hagiwara M; Mamiya S; Hidaka H
Mol Pharmacol; 1989 Jun; 35(6):760-5. PubMed ID: 2733694
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
[TBL] [Abstract][Full Text] [Related]
7. [Modulation of coronary vessel tonus: molecular and cellular mechanisms].
Busse R; Bassenge E
Z Kardiol; 1984 Aug; 73(8):477-91. PubMed ID: 6093397
[TBL] [Abstract][Full Text] [Related]
8. Calcium dependence of phorbol 12,13-dibutyrate-induced force and myosin light chain phosphorylation in arterial smooth muscle.
Singer HA; Baker KM
J Pharmacol Exp Ther; 1987 Dec; 243(3):814-21. PubMed ID: 3480353
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of diltiazem and nitroglycerin on cytosolic Ca2+ concentration and on force in the bovine ophthalmic artery.
Hiroishi G; Kobayashi S; Nishimura J; Inomata H; Kanaide H
Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2612-23. PubMed ID: 8977475
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological modulation of cardiac and vascular contractile protein function.
Silver PJ
J Cardiovasc Pharmacol; 1986; 8 Suppl 9():S34-46. PubMed ID: 2433541
[TBL] [Abstract][Full Text] [Related]
11. Structural variants of verapamil and W-7 with combined Ca2+ entry blockade/myosin phosphorylation inhibitory mechanisms.
Silver PJ; Fenichel R; Wendt RL
J Cardiovasc Pharmacol; 1988 Mar; 11(3):299-307. PubMed ID: 2452922
[TBL] [Abstract][Full Text] [Related]
12. Ca2+, calmodulin and cyclic AMP-dependent modulation of actin-myosin interactions in aorta.
Silver PJ; Holroyde MJ; Solaro RJ; Disalvo J
Biochim Biophys Acta; 1981 Apr; 674(1):65-70. PubMed ID: 6263347
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of phosphorylated myosin light chain kinase on the ATP-dependent actin-myosin interaction.
Samizo K; Okagaki T; Kohama K
Biochem Biophys Res Commun; 1999 Jul; 261(1):95-9. PubMed ID: 10405329
[TBL] [Abstract][Full Text] [Related]
14. Effects of felodipine (a dihydropyridine calcium channel blocker) and analogues on calmodulin-dependent enzymes.
Walsh MP; Sutherland C; Scott-Woo GC
Biochem Pharmacol; 1988 Apr; 37(8):1569-80. PubMed ID: 2833901
[TBL] [Abstract][Full Text] [Related]
15. Quinine inhibits vascular contraction independent of effects on calcium or myosin phosphorylation.
Adegunloye B; Lamarre E; Moreland RS
J Pharmacol Exp Ther; 2003 Jan; 304(1):294-300. PubMed ID: 12490604
[TBL] [Abstract][Full Text] [Related]
16. Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review.
Opie LH
Q J Med; 1984; 53(209):1-16. PubMed ID: 6324268
[TBL] [Abstract][Full Text] [Related]
17. Vasodilatory mechanism of levobunolol on vascular smooth muscle cells.
Dong Y; Ishikawa H; Wu Y; Yoshitomi T
Exp Eye Res; 2007 Jun; 84(6):1039-46. PubMed ID: 17459374
[TBL] [Abstract][Full Text] [Related]
18. Calcium and calmodulin antagonists binding to calmodulin and relaxation of coronary segments.
Johnson JD; Fugman DA
J Pharmacol Exp Ther; 1983 Aug; 226(2):330-4. PubMed ID: 6875846
[TBL] [Abstract][Full Text] [Related]
19. Alpha1-adrenergic signaling mechanisms in contraction of resistance arteries.
Wier WG; Morgan KG
Rev Physiol Biochem Pharmacol; 2003; 150():91-139. PubMed ID: 12884052
[TBL] [Abstract][Full Text] [Related]
20. Molecular pharmacology of calcium, calmodulin-dependent myosin phosphorylation in vascular smooth muscle.
Ishikawa T; Hidaka H
Am J Hypertens; 1990 Aug; 3(8 Pt 2):231S-234S. PubMed ID: 2222974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
